Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 47
Filter
1.
BMC Bioinformatics ; 20(Suppl 5): 180, 2019 Apr 25.
Article in English | MEDLINE | ID: mdl-31272389

ABSTRACT

BACKGROUND: Stem cells and stem cell lines are widely used in biomedical research. The Cell Ontology (CL) and Cell Line Ontology (CLO) are two community-based OBO Foundry ontologies in the domains of in vivo cells and in vitro cell line cells, respectively. RESULTS: To support standardized stem cell investigations, we have developed an Ontology for Stem Cell Investigations (OSCI). OSCI imports stem cell and cell line terms from CL and CLO, and investigation-related terms from existing ontologies. A novel focus of OSCI is its application in representing metadata types associated with various stem cell investigations. We also applied OSCI to systematically categorize experimental variables in an induced pluripotent stem cell line cell study related to bipolar disorder. In addition, we used a semi-automated literature mining approach to identify over 200 stem cell gene markers. The relations between these genes and stem cells are modeled and represented in OSCI. CONCLUSIONS: OSCI standardizes stem cells found in vivo and in vitro and in various stem cell investigation processes and entities. The presented use cases demonstrate the utility of OSCI in iPSC studies and literature mining related to bipolar disorder.


Subject(s)
Biological Ontologies , Biomedical Research/standards , Animals , Humans , Stem Cells
2.
Mol Cell Neurosci ; 73: 63-83, 2016 06.
Article in English | MEDLINE | ID: mdl-26608002

ABSTRACT

Bipolar disorder (BP) is a chronic neuropsychiatric condition characterized by pathological fluctuations in mood from mania to depression. Adoption, twin and family studies have consistently identified a significant hereditary component to BP, yet there is no clear genetic event or consistent neuropathology. BP has been suggested to have a developmental origin, although this hypothesis has been difficult to test since there are no viable neurons or glial cells to analyze, and research has relied largely on postmortem brain, behavioral and imaging studies, or has examined proxy tissues including saliva, olfactory epithelium and blood cells. Neurodevelopmental factors, particularly pathways related to nervous system development, cell migration, extracellular matrix, H3K4 methylation, and calcium signaling have been identified in large gene expression and GWAS studies as altered in BP. Recent advances in stem cell biology, particularly the ability to reprogram adult somatic tissues to a pluripotent state, now make it possible to interrogate these pathways in viable cell models. A number of induced pluripotent stem cell (iPSC) lines from BP patient and healthy control (C) individuals have been derived in several laboratories, and their ability to form cortical neurons examined. Early studies suggest differences in activity, calcium signaling, blocks to neuronal differentiation, and changes in neuronal, and possibly glial, lineage specification. Initial observations suggest that differentiation of BP patient-derived neurons to dorsal telencephalic derivatives may be impaired, possibly due to alterations in WNT, Hedgehog or Nodal pathway signaling. These investigations strongly support a developmental contribution to BP and identify novel pathways, mechanisms and opportunities for improved treatments.


Subject(s)
Bipolar Disorder/pathology , Cell Culture Techniques/methods , Induced Pluripotent Stem Cells/cytology , Bipolar Disorder/genetics , Bipolar Disorder/metabolism , Calcium Signaling , Humans , Induced Pluripotent Stem Cells/metabolism , Models, Biological , Neurogenesis , Transcriptome
3.
Nature ; 466(7307): 769-73, 2010 Aug 05.
Article in English | MEDLINE | ID: mdl-20686575

ABSTRACT

Long interspersed element-1 (LINE-1 or L1) retrotransposition continues to affect human genome evolution. L1s can retrotranspose in the germline, during early development and in select somatic cells; however, the host response to L1 retrotransposition remains largely unexplored. Here we show that reporter genes introduced into the genome of various human embryonic carcinoma-derived cell lines (ECs) by L1 retrotransposition are rapidly and efficiently silenced either during or immediately after their integration. Treating ECs with histone deacetylase inhibitors rapidly reverses this silencing, and chromatin immunoprecipitation experiments revealed that reactivation of the reporter gene was correlated with changes in chromatin status at the L1 integration site. Under our assay conditions, rapid silencing was also observed when reporter genes were delivered into ECs by mouse L1s and a zebrafish LINE-2 element, but not when similar reporter genes were delivered into ECs by Moloney murine leukaemia virus or human immunodeficiency virus, suggesting that these integration events are silenced by distinct mechanisms. Finally, we demonstrate that subjecting ECs to culture conditions that promote differentiation attenuates the silencing of reporter genes delivered by L1 retrotransposition, but that differentiation, in itself, is not sufficient to reactivate previously silenced reporter genes. Thus, our data indicate that ECs differ from many differentiated cells in their ability to silence reporter genes delivered by L1 retrotransposition.


Subject(s)
Embryonal Carcinoma Stem Cells/metabolism , Epigenesis, Genetic/genetics , Gene Silencing , Retroelements/genetics , Animals , Cell Differentiation/genetics , Cell Differentiation/physiology , Cell Line, Tumor , Chromatin/drug effects , Chromatin/genetics , Chromatin/metabolism , Chromatin Immunoprecipitation , Embryonal Carcinoma Stem Cells/pathology , Epigenesis, Genetic/drug effects , Female , Gene Expression Regulation, Neoplastic/drug effects , Gene Silencing/drug effects , Genes, Reporter/genetics , Genetic Engineering , Genetic Vectors/genetics , Genome, Human/genetics , HIV/genetics , Histone Deacetylase Inhibitors/pharmacology , Humans , Long Interspersed Nucleotide Elements/genetics , Male , Mice , Models, Genetic , Moloney murine leukemia virus/genetics , Zebrafish/genetics
4.
J Biol Chem ; 289(30): 20858-70, 2014 Jul 25.
Article in English | MEDLINE | ID: mdl-24876386

ABSTRACT

COPII-coated vesicles mediate the transport of newly synthesized proteins from the endoplasmic reticulum to the Golgi. SEC24 is the COPII component primarily responsible for recruitment of protein cargoes into nascent vesicles. There are four Sec24 paralogs in mammals, with mice deficient in SEC24A, -B, and -D exhibiting a wide range of phenotypes. We now report the characterization of mice with deficiency in the fourth Sec24 paralog, SEC24C. Although mice haploinsufficient for Sec24c exhibit no apparent abnormalities, homozygous deficiency results in embryonic lethality at approximately embryonic day 7. Tissue-specific deletion of Sec24c in hepatocytes, pancreatic cells, smooth muscle cells, and intestinal epithelial cells results in phenotypically normal mice. Thus, SEC24C is required in early mammalian development but is dispensable in a number of tissues, likely as a result of compensation by other Sec24 paralogs. The embryonic lethality resulting from loss of SEC24C occurs considerably later than the lethality previously observed in SEC24D deficiency; it is clearly distinct from the restricted neural tube phenotype of Sec24b null embryos and the mild hypocholesterolemic phenotype of adult Sec24a null mice. Taken together, these results demonstrate that the four Sec24 paralogs have developed unique functions over the course of vertebrate evolution.


Subject(s)
COP-Coated Vesicles/metabolism , Embryo, Mammalian/embryology , Embryonic Development/physiology , Vesicular Transport Proteins/metabolism , Animals , COP-Coated Vesicles/genetics , Embryo, Mammalian/cytology , Liver/cytology , Liver/embryology , Mice , Mice, Mutant Strains , Organ Specificity/physiology , Pancreas/cytology , Pancreas/embryology , Vesicular Transport Proteins/genetics
5.
Nature ; 460(7259): 1127-31, 2009 Aug 27.
Article in English | MEDLINE | ID: mdl-19657334

ABSTRACT

Long interspersed element 1 (LINE-1 or L1) retrotransposons have markedly affected the human genome. L1s must retrotranspose in the germ line or during early development to ensure their evolutionary success, yet the extent to which this process affects somatic cells is poorly understood. We previously demonstrated that engineered human L1s can retrotranspose in adult rat hippocampus progenitor cells in vitro and in the mouse brain in vivo. Here we demonstrate that neural progenitor cells isolated from human fetal brain and derived from human embryonic stem cells support the retrotransposition of engineered human L1s in vitro. Furthermore, we developed a quantitative multiplex polymerase chain reaction that detected an increase in the copy number of endogenous L1s in the hippocampus, and in several regions of adult human brains, when compared to the copy number of endogenous L1s in heart or liver genomic DNAs from the same donor. These data suggest that de novo L1 retrotransposition events may occur in the human brain and, in principle, have the potential to contribute to individual somatic mosaicism.


Subject(s)
Embryonic Stem Cells/cytology , Embryonic Stem Cells/metabolism , Neurons/cytology , Neurons/metabolism , Retroelements/genetics , 5' Untranslated Regions/genetics , Brain/cytology , Cell Line , Chromatin Immunoprecipitation , DNA Methylation , Fetus/cytology , Gene Dosage , Humans , Polymerase Chain Reaction
6.
Dev Dyn ; 242(3): 230-53, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23288605

ABSTRACT

BACKGROUND: Delineating the cascades of growth and transcription factor expression that shape the developing nervous system will improve our understanding of its molecular histogenesis and suggest strategies for cell replacement therapies. In the current investigation, we examined the ability of the proneural gene, Neurogenin1 (Neurog1; also Ngn1, Neurod3), to drive differentiation of pluripotent embryonic stem cells (ESC). RESULTS: Transient expression of Neurog1 in ESC was sufficient to initiate neuronal differentiation, and produced neuronal subtypes reflecting its expression pattern in vivo. To begin to address the molecular mechanisms involved, we used microarray analysis to identify potential down-stream targets of Neurog1 expressed at sequential stages of neuronal differentiation. CONCLUSIONS: ESC expressing Neurogenin1 begin to withdraw from cycle and form precursors that differentiate exclusively into neurons. This work identifies unique patterns of gene expression following expression of Neurog1, including genes and signaling pathways involved in process outgrowth and cell migration, regional differentiation of the nervous system, and cell cycle.


Subject(s)
Basic Helix-Loop-Helix Transcription Factors/biosynthesis , Cell Differentiation/physiology , Embryonic Stem Cells/metabolism , Gene Expression Regulation/physiology , Nerve Tissue Proteins/biosynthesis , Neural Stem Cells/metabolism , Animals , Basic Helix-Loop-Helix Transcription Factors/genetics , Cell Line , Cell Movement/physiology , Embryonic Stem Cells/cytology , Gene Expression Profiling , Mice , Nerve Tissue Proteins/genetics , Neural Stem Cells/cytology , Neurons/cytology , Neurons/metabolism , Oligonucleotide Array Sequence Analysis , Signal Transduction/physiology
7.
Cells ; 13(14)2024 Jul 15.
Article in English | MEDLINE | ID: mdl-39056776

ABSTRACT

Bipolar disorder (BP) is a recurring psychiatric condition characterized by alternating episodes of low energy (depressions) followed by manias (high energy). Cortical network activity produced by GABAergic interneurons may be critical in maintaining the balance in excitatory/inhibitory activity in the brain during development. Initially, GABAergic signaling is excitatory; with maturation, these cells undergo a functional switch that converts GABAA channels from depolarizing (excitatory) to hyperpolarizing (inhibitory), which is controlled by the intracellular concentration of two chloride transporters. The earliest, NKCC1, promotes chloride entry into the cell and depolarization, while the second (KCC2) stimulates movement of chloride from the neuron, hyperpolarizing it. Perturbations in the timing or expression of NKCC1/KCC2 may affect essential morphogenetic events including cell proliferation, migration, synaptogenesis and plasticity, and thereby the structure and function of the cortex. We derived induced pluripotent stem cells (iPSC) from BP patients and undiagnosed control (C) individuals, then modified a differentiation protocol to form GABAergic interneurons, harvesting cells at sequential stages of differentiation. qRT-PCR and RNA sequencing indicated that after six weeks of differentiation, controls transiently expressed high levels of NKCC1. Using multi-electrode array (MEA) analysis, we observed that BP neurons exhibit increased firing, network bursting and decreased synchrony compared to C. Understanding GABA signaling in differentiation may identify novel approaches and new targets for treatment of neuropsychiatric disorders such as BP.


Subject(s)
Bipolar Disorder , Cell Differentiation , GABAergic Neurons , Induced Pluripotent Stem Cells , Humans , Induced Pluripotent Stem Cells/metabolism , Induced Pluripotent Stem Cells/cytology , GABAergic Neurons/metabolism , Bipolar Disorder/metabolism , Bipolar Disorder/pathology , Solute Carrier Family 12, Member 2/metabolism , Solute Carrier Family 12, Member 2/genetics , Interneurons/metabolism
8.
Bipolar Disord ; 15(2): 177-87, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23360497

ABSTRACT

OBJECTIVES: Bipolar disorder (BD) is a mental illness of unknown neuropathology and has several genetic associations. Antipsychotics are effective for the treatment of acute mania, psychosis, or mixed states in individuals with BD. We aimed to identify gene transcripts differentially expressed in postmortem brains from antipsychotics-exposed individuals with BD (hereafter the 'exposed' group), non-exposed individuals with BD (hereafter the 'non-exposed' group), and controls. METHODS: We quantified the abundance of gene transcripts in postmortem brains from seven exposed individuals, seven non-exposed individuals, and 12 controls with the Affymetrix U133P2 GeneChip microarrays and technologies. We applied a q-value of ≤0.005 to identify statistically significant transcripts with mean abundance differences between the exposed, non-exposed and control groups. RESULTS: We identified 2191 unique genes with significantly altered expression levels in non-exposed brains compared to those in the control and exposed groups. The expression levels of these genes were not significantly different between exposed brains and controls, suggesting a normalization effect of antipsychotics on the expression of these genes. Gene ontology (GO) enrichment analysis showed significant (Bonferroni p ≤ 0.05) clustering of subgroups of the 2191 genes under many GO terms; notably, the protein products of genes enriched are critical to the function of synapses, affecting, for example, intracellular trafficking and synaptic vesicle biogenesis, transport, release and recycling, as well as organization and stabilization of the node of Ranvier. CONCLUSIONS: These results support a hypothesis of synaptic and intercellular communication impairment in BD. The apparent normalization of expression patterns with exposure to antipsychotic medication may represent a physiological process that relates both to etiology and improvement patterns of the disorder.


Subject(s)
Bipolar Disorder/pathology , Brain/metabolism , Gene Expression Regulation/physiology , Adaptor Proteins, Vesicular Transport/genetics , Adaptor Proteins, Vesicular Transport/metabolism , Adult , Antipsychotic Agents/therapeutic use , Bipolar Disorder/drug therapy , Eukaryotic Initiation Factors/genetics , Eukaryotic Initiation Factors/metabolism , Female , Gene Expression Profiling , Gene Expression Regulation/drug effects , Humans , Male , Middle Aged , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/metabolism , Oligonucleotide Array Sequence Analysis , Postmortem Changes
9.
Mol Cell Neurosci ; 49(2): 104-9, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22122823

ABSTRACT

The auditory sensory epithelium in non-mammalian vertebrates can replace lost hair cells by transdifferentiation of supporting cells, but this regenerative ability is lost in the mammalian cochlea. Future cell-based treatment of hearing loss may depend on stem cell transplantation or on transdifferentiation of endogenous cells in the cochlea. For both approaches, identification of cells with stem cell features within the mature cochlea may be useful. Here we use a Nestin-ß-gal mouse to examine the presence of Nestin positive cells in the mature auditory epithelium, and determine how overstimulation of the ear impacts these cells. Nestin positive cells were found in the apical turn of the cochlea lateral to the outer hair cell area. This pattern of expression persisted into mature age. The area of Nestin positive cells was increased after the noise lesion. This increase in area coincided with an increase in expression of the Nestin mRNA. The data suggest that cells with potential stem cell features remain in the mature mammalian cochlea, restricted to the apical turn, and that an additional set of signals is necessary to trigger their contribution to cell replacement therapy in the ear. As such, this population of cells could serve to generate cochlear stem cells for research and potential therapy, and may be a target for treatments based on induced transdifferentiation of endogenous cochlear cells.


Subject(s)
Cell Differentiation , Cell Transdifferentiation/physiology , Cochlea/cytology , Intermediate Filament Proteins/metabolism , Nerve Tissue Proteins/metabolism , Organ of Corti/metabolism , Stem Cells/metabolism , Animals , Cell Proliferation , Cochlea/metabolism , Hair Cells, Auditory/cytology , Hair Cells, Auditory/metabolism , Mice , Nestin , Noise , Organ of Corti/cytology , Rats
10.
ACS Cent Sci ; 7(11): 1809-1820, 2021 Nov 24.
Article in English | MEDLINE | ID: mdl-34841055

ABSTRACT

Lithium has been a drug for bipolar disorders (BD) for over 70 years; however, its usage has been limited by its narrow therapeutic window (between 0.6 and 1.2 mM). Understanding the cellular distribution of lithium ions (Li+) in patient cells will offer deep insight into this limitation, but selective imaging of Li+ in living cells under biomedically relevant concentration ranges has not been achieved. Herein, we report in vitro selection and development of a Li+-specific DNAzyme fluorescent sensor with >100-fold selectivity over other biorelevant metal ions. This sensor allows comparative Li+ visualization in HeLa cells, human neuronal progenitor cells (NPCs), and neurons derived from BD patients and healthy controls. Strikingly, we detected enhanced accumulation of Li+ in cells derived from BD patients compared with healthy controls in differentiated neurons but not NPCs. These results establish the DNAzyme-based sensor as a novel platform for biomedical research into BD and related areas using lithium drugs.

11.
Sci Rep ; 11(1): 21100, 2021 10 26.
Article in English | MEDLINE | ID: mdl-34702932

ABSTRACT

The COPII component SEC24 mediates the recruitment of transmembrane cargos or cargo adaptors into newly forming COPII vesicles on the ER membrane. Mammalian genomes encode four Sec24 paralogs (Sec24a-d), with two subfamilies based on sequence homology (SEC24A/B and C/D), though little is known about their comparative functions and cargo-specificities. Complete deficiency for Sec24d results in very early embryonic lethality in mice (before the 8 cell stage), with later embryonic lethality (E7.5) observed in Sec24c null mice. To test the potential overlap in function between SEC24C/D, we employed dual recombinase mediated cassette exchange to generate a Sec24cc-d allele, in which the C-terminal 90% of SEC24C has been replaced by SEC24D coding sequence. In contrast to the embryonic lethality at E7.5 of SEC24C-deficiency, Sec24cc-d/c-d pups survive to term, though dying shortly after birth. Sec24cc-d/c-d pups are smaller in size, but exhibit no other obvious developmental abnormality by pathologic evaluation. These results suggest that tissue-specific and/or stage-specific expression of the Sec24c/d genes rather than differences in cargo export function explain the early embryonic requirements for SEC24C and SEC24D.


Subject(s)
Embryonic Development , Genetic Complementation Test , Vesicular Transport Proteins , Animals , Mice , Mice, Transgenic , Vesicular Transport Proteins/biosynthesis , Vesicular Transport Proteins/genetics
12.
Lab Chip ; 10(21): 2959-64, 2010 Nov 07.
Article in English | MEDLINE | ID: mdl-20835429

ABSTRACT

Generation of stable soluble-factor gradients in microfluidic devices enables studies of various cellular events such as chemotaxis and differentiation. However, many gradient devices directly expose cells to constant fluid flow and that can induce undesired responses from cells due to shear stress and/or wash out of cell-secreted molecules. Although there have been devices with flow-free gradients, they typically generate only a single condition and/or have a decaying gradient profile that does not accommodate long-term experiments. Here we describe a microdevice that generates several chemical gradient conditions on a single platform in flow-free microchambers which facilitates steady-state gradient profiles. The device contains embedded normally-closed valves that enable fast and uniform seeding of cells to all microchambers simultaneously. A network of microchannels distributes desired solutions from easy-access open reservoirs to a single output port, enabling a simple setup for inducing flow in the device. Embedded porous filters, sandwiched between the microchannel networks and cell microchambers, enable diffusion of biomolecules but inhibit any bulk flow over the cells.


Subject(s)
Microfluidics/instrumentation , Animals , Embryonic Stem Cells/cytology , Mice
13.
Mol Cell Proteomics ; 7(4): 750-67, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18304949

ABSTRACT

Elucidating the complex combinations of growth factors and signaling molecules that maintain pluripotency or, alternatively, promote the controlled differentiation of human embryonic stem cells (hESCs) has important implications for the fundamental understanding of human development, devising cell replacement therapies, and cancer cell biology. hESCs are commonly grown on irradiated mouse embryonic fibroblasts (MEFs) or in conditioned medium from MEFs. These culture conditions interfere with many experimental conclusions and limit the ability to perform conclusive proteomics studies. The current investigation avoided the use of MEFs or MEF-conditioned medium for hESC culture, allowing global proteomics analysis without these confounding conditions, and elucidated neural cell-specific signaling pathways involved in noggin-induced hESC differentiation. Based on these analyses, we propose the following early markers of hESC neural differentiation: collapsin response mediator proteins 2 and 4 and the nuclear autoantigenic sperm protein as a marker of pluripotent hESCs. We then developed a directed mass spectrometry assay using multiple reaction monitoring (MRM) to identify and quantify these markers and in addition the epidermal ectoderm marker cytokeratin-8. Analysis of global proteomics, quantitative RT-PCR, and MRM data led to testing the isoform interference hypothesis where redundant peptides dilute quantification measurements of homologous proteins. These results show that targeted MRM analysis on non-redundant peptides provides more exact quantification of homologous proteins. This study describes the facile transition from discovery proteomics to targeted MRM analysis and allowed us to identify and verify several potential biomarkers for hESCs during noggin-induced neural and BMP4-induced epidermal ectoderm differentiation.


Subject(s)
Cell Culture Techniques/methods , Cell Differentiation , Embryonic Stem Cells/metabolism , Pluripotent Stem Cells/metabolism , Proteins/analysis , Proteomics/methods , Amino Acid Sequence , Biomarkers/analysis , Biomarkers/metabolism , Bone Morphogenetic Protein 4 , Bone Morphogenetic Proteins/pharmacology , Carrier Proteins/pharmacology , Cell Differentiation/drug effects , Embryonic Stem Cells/cytology , Embryonic Stem Cells/drug effects , Epidermal Cells , Epidermis/chemistry , Epidermis/metabolism , Humans , Mass Spectrometry , Molecular Sequence Data , Neurons/chemistry , Neurons/cytology , Neurons/metabolism , Peptides/analysis , Pluripotent Stem Cells/cytology , Pluripotent Stem Cells/drug effects , Proteins/genetics , Proteins/metabolism , RNA, Messenger/analysis , RNA, Messenger/metabolism
14.
Stem Cells Dev ; 29(17): 1145-1159, 2020 09 01.
Article in English | MEDLINE | ID: mdl-32438891

ABSTRACT

Bipolar disorder (BP) is a complex psychiatric condition characterized by severe fluctuations in mood for which underlying pathological mechanisms remain unclear. Family and twin studies have identified a hereditary component to the disorder, but a single causative gene (or set of genes) has not been identified. MicroRNAs (miRNAs) are small, noncoding RNAs ∼20 nucleotides in length, that are responsible for the posttranslational regulation of multiple genes. They have been shown to play important roles in neural development as well as in the adult brain, and several miRNAs have been reported to be dysregulated in postmortem brain tissue isolated from bipolar patients. Because there are no viable cellular models to study BP, we have taken advantage of the recent discovery that somatic cells can be reprogrammed to pluripotency then directed to form the full complement of neural cells. Analysis of RNAs extracted from Control and BP patient-derived neurons identified 58 miRNAs that were differentially expressed between the two groups. Using quantitative polymerase chain reaction we validated six miRNAs that were elevated and two miRNAs that were expressed at lower levels in BP-derived neurons. Analysis of the targets of the miRNAs indicate that they may regulate a number of cellular pathways, including axon guidance, Mapk, Ras, Hippo, Neurotrophin, and Wnt signaling. Many are involved in processes previously implicated in BP, such as cell migration, axon guidance, dendrite and synapse development, and function. We have validated targets of several different miRNAs, including AXIN2, BDNF, RELN, and ANK3 as direct targets of differentially expressed miRNAs using luciferase assays. Identification of pathways altered in patient-derived neurons suggests that disruption of these regulatory networks that may contribute to the complex phenotypes in BP.


Subject(s)
Axon Guidance/genetics , Bipolar Disorder/genetics , Bipolar Disorder/pathology , Cell Differentiation/genetics , Induced Pluripotent Stem Cells/metabolism , MicroRNAs/genetics , Neuronal Plasticity/genetics , Neurons/metabolism , Cells, Cultured , Gene Expression Regulation , Gene Ontology , Humans , Phenotype , Reelin Protein , Reproducibility of Results
15.
Front Cell Dev Biol ; 8: 588941, 2020.
Article in English | MEDLINE | ID: mdl-33178701

ABSTRACT

Neural rosettes (NPC rosettes) are radially arranged groups of cells surrounding a central lumen that arise stochastically in monolayer cultures of human pluripotent stem cell (hPSC)-derived neural progenitor cells (NPC). Since NPC rosette formation is thought to mimic cell behavior in the early neural tube, these rosettes represent important in vitro models for the study of neural tube morphogenesis. However, using current protocols, NPC rosette formation is not synchronized and results are inconsistent among different hPSC lines, hindering quantitative mechanistic analyses and challenging live cell imaging. Here, we report a rapid and robust protocol to induce rosette formation within 6 h after evenly-sized "colonies" of NPC are generated through physical cutting of uniformly polarized NESTIN+/PAX6+/PAX3+/DACH1+ NPC monolayers. These NPC rosettes show apically polarized lumens studded with primary cilia. Using this assay, we demonstrate reduced lumenal size in the absence of PODXL, an important apical determinant recently identified as a candidate gene for juvenile Parkinsonism. Interestingly, time lapse imaging reveals that, in addition to radial organization and apical lumen formation, cells within cut NPC colonies initiate rapid basally-driven spreading. Further, using chemical, genetic and biomechanical tools, we show that NPC rosette morphogenesis requires this basal spreading activity and that spreading is tightly regulated by Rho/ROCK signaling. This robust and quantitative NPC rosette platform provides a sensitive system for the further investigation of cellular and molecular mechanisms underlying NPC rosette morphogenesis.

16.
J Neurosci ; 28(48): 12622-31, 2008 Nov 26.
Article in English | MEDLINE | ID: mdl-19036956

ABSTRACT

Differentiation of the pluripotent neuroepithelium into neurons and glia is accomplished by the interaction of growth factors and cell-type restricted transcription factors. One approach to obtaining a particular neuronal phenotype is by recapitulating the expression of these factors in embryonic stem (ES) cells. Toward the eventual goal of auditory nerve replacement, the aim of the current investigation was to generate auditory nerve-like glutamatergic neurons from ES cells. Transient expression of Neurog1 promoted widespread neuronal differentiation in vitro; when supplemented with brain-derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF), 75% of ES cell-derived neurons attained a glutamatergic phenotype after 5 d in vitro. Mouse ES cells were also placed into deafened guinea pig cochleae and Neurog1 expression was induced for 48 h followed by 26 d of BDNF/GDNF infusion. In vivo differentiation resulted in 50-75% of ES cells bearing markers of early neurons, and a majority of these cells had a glutamatergic phenotype. This is the first study to report a high percentage of ES cell differentiation into a glutamatergic phenotype and sets the stage for cell replacement of auditory nerve.


Subject(s)
Basic Helix-Loop-Helix Transcription Factors/metabolism , Embryonic Stem Cells/transplantation , Glutamic Acid/metabolism , Nerve Growth Factors/pharmacology , Nerve Tissue Proteins/metabolism , Neurogenesis/physiology , Stem Cell Transplantation/methods , Animals , Basic Helix-Loop-Helix Transcription Factors/genetics , Biomarkers/analysis , Biomarkers/metabolism , Brain-Derived Neurotrophic Factor/metabolism , Brain-Derived Neurotrophic Factor/pharmacology , Cell Differentiation/drug effects , Cell Differentiation/physiology , Cell Line , Cells, Cultured , Cochlear Nerve/drug effects , Cochlear Nerve/embryology , Cochlear Nerve/metabolism , Deafness/chemically induced , Deafness/metabolism , Deafness/surgery , Doxycycline/pharmacology , Embryonic Stem Cells/drug effects , Embryonic Stem Cells/metabolism , Glial Cell Line-Derived Neurotrophic Factor/metabolism , Glial Cell Line-Derived Neurotrophic Factor/pharmacology , Guinea Pigs , Humans , Mice , Nerve Growth Factors/metabolism , Nerve Tissue Proteins/drug effects , Nerve Tissue Proteins/genetics , Neurogenesis/drug effects , Phenotype , Sensory Receptor Cells/drug effects , Sensory Receptor Cells/metabolism
17.
Sci Rep ; 9(1): 11434, 2019 08 07.
Article in English | MEDLINE | ID: mdl-31391476

ABSTRACT

The highly conserved SNARE protein SEC22B mediates diverse and critical functions, including phagocytosis, cell growth, autophagy, and protein secretion. However, these characterizations have thus far been limited to in vitro work. Here, we expand our understanding of the role Sec22b plays in vivo. We utilized Cre-Lox mice to delete Sec22b in three tissue compartments. With a germline deletion of Sec22b, we observed embryonic death at E8.5. Hematopoietic/endothelial cell deletion of Sec22b also resulted in in utero death. Notably, mice with Sec22b deletion in CD11c-expressing cells of the hematopoietic system survive to adulthood. These data demonstrate Sec22b contributes to early embryogenesis through activity both in hematopoietic/endothelial tissues as well as in other tissues yet to be defined.


Subject(s)
Embryonic Development , Endothelial Cells/metabolism , Hematopoietic System/embryology , R-SNARE Proteins/metabolism , Animals , Embryo, Mammalian , Female , Male , Mice , Mice, Knockout , R-SNARE Proteins/genetics
18.
Hear Res ; 242(1-2): 110-6, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18585449

ABSTRACT

The successful function of cochlear prostheses depends on activation of auditory nerve. The survival of auditory nerve neurons, however, can vary widely in candidates for cochlear implants and influence implant efficacy. Stem cells offer the potential for improving the function of cochlear prostheses and increasing the candidate pool by replacing lost auditory nerve. The first phase of studies for stem cell replacement of auditory nerve has examined the in vitro survival and differentiation as well as in vivo differentiation and survival of exogenous embryonic and tissue stem cells placed into scala tympani and/or modiolus. These studies are reviewed and new results on in vivo placement of B-5 mouse embryonic stem cells into scala tympani of the guinea pig cochleae with differentiation into a glutamatergic neuronal phenotype are presented. Research on the integration and connections of stem cell derived neurons in the cochlea is described. Finally, an alternative approach is considered, based on the use of endogenous progenitors rather than exogenous stem cells, with a review of promising findings that have identified stem cell-like progenitors in cochlear and vestibular tissues to provide the potential for auditory nerve replacement.


Subject(s)
Cochlear Nerve/physiology , Embryonic Stem Cells/transplantation , Stem Cell Transplantation/methods , Animals , Cell Differentiation/physiology , Cell Survival/physiology , Cochlear Nerve/cytology , Deafness/surgery , Embryonic Stem Cells/cytology , Guinea Pigs , Mice , Mice, Inbred Strains , Models, Animal , Scala Tympani/cytology , Scala Tympani/physiology
19.
Birth Defects Res B Dev Reprod Toxicol ; 83(4): 446-56, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18702117

ABSTRACT

A meeting was convened so that users of three models for in vitro developmental toxicity (embryonic stem cells, whole embryo culture, and zebrafish) could share their experiences with each model, and explore the areas for improvement. We present a summary of this meeting and the recommendations of the group.


Subject(s)
Embryo Culture Techniques/methods , Embryonic Stem Cells/cytology , Toxicity Tests/methods , Zebrafish/embryology , Animals , Embryo, Mammalian/cytology , Embryo, Nonmammalian/cytology , Mice
20.
Exp Biol Med (Maywood) ; 232(10): 1368-80, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17959850

ABSTRACT

To fully understand self-renewal and pluripotency and their regulation in human embryonic stem cells (hESCs), it is necessary to generate genetically modified cells and analyze the consequences of elevated and reduced expression of genes. Genes expressed in hESCs using plasmid vectors, however, are subject to silencing. Moreover, hESCs have a low plating efficiency when dissociated to single cells, making creation of subcloned lines inefficient. In addition to overexpression experiments, it is important to perform loss-of-function studies, which can be achieved rapidly using RNA interference (RNAi). We report stable long-term expression of enhanced green fluorescent protein (eGFP) in hESCs using a lentiviral vector, and establishment of an eGFP-expressing subline (RG6) using manual dissection. To demonstrate the efficacy of RNAi in hESCs, an RNAi expression vector was used to achieve reduced expression of eGFP in hESCs. To evaluate the role of OCT4 in the regulation of hESC self-renewal and differentiation, a vector expressing a hairpin RNA targeting endogenous expression of OCT4 was constructed. In a novel experiment in hESCs, the OCT4 cDNA sequence was cloned into an expression vector to allow for the transient upregulation of OCT4 in hESCs. The ability to manipulate levels of OCT4 above and below enodogenous levels allows the determination of OCT4 function in hESCs. Specifically, reduced expression of OCT4 in hESCs promoted upregulation of markers indicative of mesoderm and endoderm differentiation, and elevated levels of OCT4 in hESCs promoted upregulation of markers indicative of endoderm derivatives. Thus, both upregulation and downregulation of Oct4 in hESCs results in differentiation, but with patterns distinct from parallel experiments in mice.


Subject(s)
Embryonic Stem Cells/cytology , Embryonic Stem Cells/physiology , Octamer Transcription Factor-3/genetics , Base Sequence , Cell Differentiation , Cell Line , Electroporation , Genes, Reporter , Humans , Immunohistochemistry , Molecular Sequence Data , Octamer Transcription Factor-3/metabolism , RNA Interference , Reverse Transcriptase Polymerase Chain Reaction , Transfection
SELECTION OF CITATIONS
SEARCH DETAIL